Abstract: The present disclosure relates to relates to mobile diagnostic system having portable compact mobile laboratory that is retrofitted on a vehicle. The portable compact mobile laboratory in the mobile diagnostic system is equipped with medical equipments, IT parts, reagents and accessories which are required for diagnostic services. The mobile diagnostic system is also equipped with data recorder integrated with patient data management software to enable teleconsultation with the doctors. The mobile diagnostic system of the present invention is easy to use, is less expensive, more compact and has less complexity.
The present invention relates to a mobile diagnostic system having portable compact mobile laboratory that is retrofitted on a vehicle.
BACKGROUND OF THE INVENTION
[0002] Over the recent years, diagnostic tests have become an essential feature of clinical practice. Many of the critical decisions in diagnosis and treatment of patients involve quantifiable laboratory data. The detection and characterization of the pathogens and their immunological consequences are the necessary starting points. However, healthcare industry currently faces a problem relating to shortage of pathology laboratories and testing facilities for diagnostic purposes. This problem is more evident in the rural and non-metro areas specifically; villages, hilly areas, desert areas of less economically developed nations where there is a significant dearth of high-quality diagnostic services. Many times, laboratories even if available in the rural and non-metro areas are not equipped well to support the correct and accurate investigations for diagnosis. As a result of this, people from rural or non-metro areas have to go to cities for better diagnostic services as well as better medical treatment.
[0003] In the other scenario, the medical clinic for consultation with the doctor and diagnostic centres are at different places. In such cases, the patient goes to a doctor and the doctor writes the test for patient and the patient has to go on different location for the same. In most cases, the patient gets the test report another day and subsequently he gets the medicine according to his problem in the reports. All this leads to the delay in the treatment as well as inconvenience for the patient who is already unwell and weak.
[0004] A robust diagnostic facility which is accessible to the patients at the time of their urgency is the need of an hour. Further, a place wherein complete consultation, diagnostic and medicine prescription can be provided to the patient at one place shall be beneficial. This will help in better patient management, prevent the spread of diseases and at the same time reduce the mortality rates.
[0005] Many attempts have been made at integrating diagnostic testing functionality with smartphones effectively. Reference may be made to US Patent application no. US 20130203043 which discloses portable rapid diagnostic test reader system having a smart phone with a camera and one or more processors contained within the smart phone; a modular housing having a receptacle configured to receive a sample tray; at least one illumination source and an optical demagnifier disposed in the modular housing. Modular housing mentioned in this patent application is configured to mount to the smart phone.
[0006] European patent application no. i.e., EP2893477 disclose mobile platform for the analysis of colorimetric test strips and disease management using readings produced by this analysis. More specifically, the camera of the mobile device can be used to automatically detect the colour of one or several reagent areas of the colorimetric strip. Further, these one or several colours are compared against a set of known or standard colours previously detected from a reference and/or calibration colour chart in an initial calibration and stored in the memory of the mobile device. Each of these standard colours can be associated to a specific test result reading for which the colorimetric strip is testing. These one or several detected values are then employed in a disease management platform on the mobile device.
[0007] Other attempts have been made to integrate diagnostic testing feature with computer or a user-interface device. U.S Patent Application No. US20030106940 discloses a portable medical diagnostic device and a miniature identification capture reader. The identification capture reader according to this application could be a barcode scanner, imager, infrared identification reader or similar technology and the subcomponents of the medical device diagnostic may be a battery, display, keyboard, cradle, wireless communications circuitry, memory, housing, central processing unit (CPU) and telephony components.
[0008] Still further, European patent application no. viz. EP3456264 discloses portable system which has a portable ultrasonic diagnostic device and an ultrasonic diagnostic application which is installed in a portable terminal. The application receives ultrasonic image data from the portable ultrasonic diagnostic device, and displays an ultrasonic image through a display screen of the portable terminal. Further, there is an ultrasonic image server which stores guiding ultrasonic images for each diagnosis location and diagnosed part.
[0009] Another patent application IN 202011040621 disclose portable device and method for measuring the cardiac electrical activity of a patient, by transmitting the measured cardiac electrical activity to a user-interface device for user interpretation.
[0010] The devices disclosed in these patent applications are inconclusive as they do not provide the particulars of the software to be used and also do not provide any details of the diagnostic test which can be performed. Further, devices disclosed in these patent applications also have a variety of other disadvantages vis-à-vis require more space, are more complex, and are also expensive. Also, because of the requirement of interface, software applications and computer, these devices may require the person skilled person to carry out the procedure and a person skilled in the use of specialized software to extract the data.
[0011] Lastly and most importantly, accessibility of internet is a major issue in the rural and non-metro areas of less economically developed nations which makes it almost impossible to use portable wireless medical devices through the internet.
[0012] In view of the above limitations, there exists a need to develop an improved approach and devices or apparatuses which would in turn address a variety of issues including, but not limited to, high costs, more complex, dependency on internet and requirement of trained technicians for carrying out the procedures to extract the data. Thus, the above-described deficiencies of conventional approaches and devices thereof, are merely intended to provide an overview of some of the problems of conventional approaches and are not intended to be exhaustive. Other problems with conventional approaches, and devices and their corresponding benefits of the various non-limiting embodiments described herein may become further apparent upon review of the following description.
SUMMARY OF THE INVENTION
[0013] The following presents a simplified summary of the invention to provide a basic understanding of some aspects of the invention. This summary is not an extensive overview of the present invention. It is not intended to identify the key/critical elements of the invention or to delineate the scope of the invention. Its sole purpose is to present some concept of the invention in a simplified form as a prelude to a more detailed description of the invention presented later.
[0014] An aspect of the present invention encompasses a mobile diagnostic system having portable compact mobile laboratory that is retrofitted on a vehicle.
[0015] Another aspect of the present invention encompasses a mobile diagnostic system wherein healthcare services can be provided at the doorstep of the patient.
[0016] Another aspect of the present invention encompasses a mobile diagnostic system which has been designed to operate at extreme temperatures i.e. between 0° C to 50° C, because of which it can provide accurate results in hilly areas as well as desert areas. In addition to this, there is no requirement of no warm up and cooling time for operations.
[0017] Another aspect of the present invention encompasses a mobile diagnostic system wherein portable compact mobile laboratory is equipped with medical equipments, IT parts, reagents, accessories which are required for diagnostic services.
[0018] Another aspect of the present invention encompasses a mobile diagnostic system wherein portable compact mobile laboratory is also equipped with ultra-portable foldable tent house which covers the entire diagnostic system.
[0019] Yet another aspect of the present invention encompasses a mobile diagnostic system wherein multiple diagnostic tests can be performed using the compact mobile laboratory, making the diagnostic system more cost effective.
[0020] Yet another aspect of the present invention encompasses a mobile diagnostic system which is easy to use, is less expensive, more compact and has less complexity.
[0021] Yet another aspect of the present invention encompasses a mobile diagnostic system which has less power consumption and less running cost.
[0022] Further, an aspect of the present invention encompasses a mobile diagnostic system which has bio-waste management facility with power back up.
[0023] Still further aspect of the present invention encompasses a mobile diagnostic system which has GPRS Tracker for better route management and decrease response times for improved customer service.
[0024] Still further aspect of the present invention encompasses a mobile diagnostic system having data recorder integrated with patient data management software to enable teleconsultation with the doctors.
[0025] Other aspects, advantages, and salient features of the invention will become apparent to those skilled in the art from the following detailed description, which, details the invention in different embodiments.
BRIEF DESCRIPTION OF THE DRAWINGS
[0026] While the specification concludes with claims that particularly point out and distinctly claim the invention, it is believed that the advantages and features of the present invention will become better understood with reference to the following more detailed description of expressly disclosed exemplary embodiments taken in conjunction with the accompanying drawings. The drawings and detailed description which follow are intended to be merely illustrative of the expressly disclosed exemplary embodiments and are not intended to limit the scope of the present invention as set forth in the appended claims. In the drawings:
[0027] FIG. 1 is a view schematically illustrating a mobile diagnostic system having portable compact mobile laboratory with ultra-portable foldable tent house retrofitted on a vehicle according to the embodiment of the present invention;
[0028] FIG. 2 is a view schematically illustrating a mobile diagnostic system having portable compact mobile laboratory according to the embodiment of the present invention.
[0029] Fig 3 is a view schematically illustrating a portable compact mobile laboratory according to the embodiment of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
[0030] For purposes of the present invention, the following abbreviations apply:
ECG : Electrocardiography
BMI : Body mass index
IT : Information technology
DC : Direct Current
TG Reagent : Triglyceride reagents
KFT : Kidney Function Test
LFT : Liver Function Test
PP blood sugar : Post Prandial
HDL : High-density lipoprotein
LDL : Low-density lipoprotein
SGOT : Serum glutamic-oxaloacetic transaminase
SGPT : Serum glutamic pyruvic transaminase
ALP : Alkaline phosphatase
EGFR : Estimated glomerular filtration rate
AG ratio : Albumin-Globulin ratio (A/G)
PCT : Procalcitonin
HCT : Haematocrit
MCH : Mean corpuscular haemoglobin
PCV : Packed Cell Volume.
P-LCR : Platelet-large cell ratio
MCV : Mean corpuscular volume
WBC : White blood cells
MCHC : Mean corpuscular haemoglobin concentration
RBC : Red blood cells
PLCC : Primary Liver Cell Carcinoma
HCV : Hepatitis C virus
CRP : C-Reactive Protein
HBSAG : Hepatitis B surface antigen
VDRL : Venereal disease research laboratory
[0031] This section is intended to provide an explanation and description of various possible embodiments of the present invention. The examples used herein are intended only to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable the person skilled in the art to practice the embodiments used herein. Also, the examples/embodiments described herein should not be construed as limiting the scope of the embodiments herein.
[0032] The use of terms “including,” “comprising,” or “having” and variations thereof herein are meant to encompass the items listed thereafter and equivalents thereof as well as additional items.
[0033] Further, the terms, “an” and “a” herein do not denote a limitation of quantity, but rather denote the presence of at least one of the referenced items.
[0034] Referring to Figure. 1, Figure 2 and Figure 3; the invention will now be described in more detail. A mobile diagnostic system, as shown in Figure 1 comprises mobile diagnostic system having portable compact mobile laboratory, as shown in Figure 2 and Figure 3 with ultra-portable foldable tent house retrofitted on a vehicle.
[0035] The mobile diagnostic system having compact mobile laboratory is retrofitted on a vehicle.
[0036] In an embodiment, the vehicle may be a 2-wheeler, 3-wheeler or 4- wheeler. In a preferred embodiment, the vehicle is a 2-wheeler.
[0037] In an embodiment, the mobile diagnostic system is used for diagnostic purpose.
[0038] In an embodiment, the mobile diagnostic system can be used to perform multiple diagnostic tests, making it more cost effective.
[0039] In another embodiment, the mobile diagnostic system prevents the delay in the treatment, helps in better patient management, prevent the spread of diseases and at the same time reduce the mortality rate.
[0040] In yet another embodiment, unlike the most diagnostic systems currently available, the mobile diagnostic system of the present invention is independent of the requirement of maintenance of temperature and humidity. In addition to this, there is no requirement of no warm up and cooling time for operations.
[0041] The mobile diagnostic system has been designed to operate at extreme temperatures i.e. between 0° C to 50° C, because of which it can provide accurate results in hilly areas as well as desert areas.
[0042] In accordance with an embodiment of the present invention, portable compact mobile laboratory is equipped with medical equipments, IT parts, reagents, accessories and consumables which are required for diagnostic services.
[0043] The medical equipments may include but are not limited to biochemical analysers, microscope, incubators, centrifuge, micropipettes, washing systems, cuvettes stand, tip boxes, tips stand, solar panel, computer-based ECG, portable cold storage unit/fridge, temperature thermometer, blood pressure machine, portable BMI machine, Neubauer chamber, tourniquet, manual needle cutter and manual cell counter.
[0044] In a preferred embodiment, the microscope is connected with the mobile device with the bluetooth. It has an auto-focus feature with automatic screening of the slide. Further, the microscope is capable of capturing images and videos of the biological specimen and the path of the images and videos is pre-defined by the mobile device.
[0045] The IT part in the portable compact mobile laboratory may include but are not limited to DC buck convertor, charging cable, satellite control and cloud computing and data recorder or tablet with patient data management software.
[0046] The reagents in the portable compact mobile laboratory may include but are not limited glucose reagent, bilirubin reagent, albumin reagent, TG reagent, total cholesterol reagent, AST (SGOT), total protein reagent, creatinine reagent, uric acid reagent, eosinophil diluting fluid, field’s stain (A and B), Widal and blood group reagent.
[0047] The accessories and consumables in the portable compact mobile laboratory may include but are not limited to gloves, coverslip, sodium hypochlorite, syringe, cotton, label stickers, pregnancy kit, urine multi stick, glass slide, ESR tube (plastic), side boxes (left and right), tray box, leg guard, chair & stool and tray (left and right).
[0048] In another embodiment of the present invention, portable compact mobile laboratory is also equipped with ultra-portable foldable tent house.
[0049] Ultra-portable foldable tent house is an instant pop-up tent and covers the entire laboratory work. Further, foldable tent house is light in weight, yet made up of material which is unbreakable and rugged and can endure extreme temperature conditions.
[0050] In accordance with an embodiment of the present invention, the diagnostic services that may be conducted are blood pressure monitoring, temperature monitoring, BMI monitoring, biochemistry tests, lipid profile test, ECG, haematology test, KFT-LFT tests, serology test, urine tests and electrolyte tests.
[0051] Biochemistry tests that may be performed include but are not limiting to fasting blood sugar, random blood sugar and PP blood sugar test for measuring the amount of glucose or sugar circulating in a person’s blood.
[0052] Serum lipid profile may include test for determining the level of total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, HDL-LDL ratio, cholesterol-HDL ratio in the blood serum.
[0053] KFT and LFT may include the tests to determine the level of uric acid, BUN, Creatinine, urea , EGFR, AG ratio, Bilirubin, Indirect bilirubin, globulin, total protein, albumin, direct and indirect bilirubin, SGOT, SGPT and ALP level.
[0054] Further, haematology tests may include test to determine the platelets count, PCT level, HCT level, MCH level, haemoglobin level, PCV level, P-LCR level, granulocyte level, MCV, WBC count, lymphocyte count, MCHC count, RBC count and PLCC levels. Haematological tests can hecountlp diagnose anaemia, infection, haemophilia, blood-clotting disorders, and leukaemia.
[0055] In a preferred embodiment, haematology tests are performed using staining kit which comprises a plurality of containers/vessels and a staining apparatus wherein said staining apparatus is capable of holding plurality of glass slides. This enables staining of multiple glass slides together, makes the staining process less intensive and reduces time. Further, it also makes mobile diagnostic system more cost effective.
[0056] Since there is no blood collection cost as there is no transportation or use of anticoagulants and vials, the running cost of mobile diagnostic system is very low, which also makes it cost effective.
[0057] Serological tests that may be included but are not limited to typhidot test, widal test, HCV tests, CRP levels, HBSAG tests, pregnancy tests, VDRL tests , RA factor determination, semen fructose, malaria antigen test, semen analysis and dengue NSI antigen.
[0058] Urine analysis may include determination of leukocyte level, bilinogen, nitrite, PH test, specific gravity test, ketone test, bilirubin level and glucose level in the urine. Further, tests for appearance, color, quantity and presence of bacteria in the urine may be also determined.
[0059] In yet another embodiment, a mobile diagnostic system has a data recorder which is integrated with patient data management software. Collected and integrated data helps to facilitate teleconsultation with the doctors which in turn results in improved patient engagement with remote monitoring. So, patient’s complete consultation, diagnostic and medicine prescription can be done at one place. Additionally, this also helps to bridge the physical distance and time between patients in remote areas and medical specialists around the world. Further, teleconsultation is more beneficial for the cases such as monitoring immobilized patients, post-surgical follow-up, behavioural health, COVID-19 cases as well as urgent care.
[0060] As is apparent from the above description the present invention provides the mobile diagnostic system having portable compact mobile laboratory which has the following advantages:
• It is easy to use and less expensive.
• It is more compact and has less complexity.
• It provides for the easy handling and is economical.
• It can be used for performing multiple diagnostic tests.
• It has low power consumption.
• It has a data recorder integrated with patient data management software which helps to facilitates teleconsultation with the doctors.
• It has power back up and GPRS tracker for better route management and decrease response times for improved customer service.
• It has an ability to operate at extreme temperatures i.e., between 0° C to 50° C, because of which it can provide accurate results in hilly areas as well as desert areas.
• Lastly, since the mobile laboratory is retrofitted on a vehicle, it can be used and send for diagnosis even in rural and non-metro areas where there is a shortage of laboratories.
[0061] While the disclosure has been presented with respect to certain specific embodiments, it will be appreciated that many modifications and changes may be made by those skilled in the art without departing from the spirit and scope of the disclosure. It is intended, therefore, by the appended claims to cover all such modifications and changes as fall within the true spirit and scope of the disclosure.
We Claim:
1. A mobile diagnostic system comprising portable compact mobile laboratory that is retrofitted on a vehicle.
2. The mobile diagnostic system of claim 1, wherein vehicle may be 2-wheeler, 3-wheeler or 4- wheeler.
3. The mobile diagnostic system of claim 2, wherein the preferred vehicle may be 2-wheeler.
4. The mobile diagnostic system of claim 1, wherein the portable compact mobile laboratory is equipped with medical equipments, IT parts, reagents, accessories which are required for diagnostic services.
5. The mobile diagnostic system of claim 4, wherein medical equipments may include but are not limited to incubators, biochemical analysers, microscope, centrifuge, micropipettes, washing systems, cuvettes stand, tips stand, solar panel, computer-based ECG, portable cold storage unit/fridge, temperature thermometer, blood pressure machine, portable BMI machine, Neubauer chamber, tourniquet, manual needle cutter and manual cell counter.
6. The mobile diagnostic system of claim 4, wherein the IT part in the portable compact mobile laboratory may include but are not limited to DC buck convertor, charging cable, patient management software, satellite control and cloud computing and data recorder or tablet.
7. The mobile diagnostic system of claim 4, wherein the reagents in the portable compact mobile laboratory may include but are not limited to glucose reagent, bilirubin reagent, albumin reagent, TG reagent, total cholesterol reagent, AST (SGOT), total protein reagent, creatinine reagent, uric acid reagent, eosinophil diluting fluid, field’s stain (A&B), widal and blood group reagent.
8. The mobile diagnostic system of claim 4, wherein the accessories and consumables in the portable compact mobile laboratory may include but are not limited to gloves, coverslip, sodium hypochlorite, syringe, cotton, label stickers, pregnancy kit, urine multi stick, glass slide, ESR tube (plastic), side boxes (left and right), tray box, leg guard, chair and stool and tray (left and right).
9. The mobile diagnostic system of claim 4, wherein portable compact mobile laboratory is equipped with ultra-portable foldable tent house tent which covers the diagnostic system.
10. The mobile diagnostic system of claim 1, wherein diagnostic services that may be conducted are blood pressure monitoring, temperature monitoring, BMI monitoring, biochemistry test, lipid profile, ECG, haematology test, KFT-LFT tests, serology test, urine tests and electrolyte tests.
| Section | Controller | Decision Date |
|---|---|---|
| # | Name | Date |
|---|---|---|
| 1 | 202111044084-FORM 4 [21-12-2024(online)].pdf | 2024-12-21 |
| 1 | 202111044084-FORM 4 [29-11-2023(online)].pdf | 2023-11-29 |
| 1 | 202111044084-STATEMENT OF UNDERTAKING (FORM 3) [29-09-2021(online)].pdf | 2021-09-29 |
| 2 | 202111044084-ASSIGNMENT WITH VERIFIED COPY [06-10-2022(online)].pdf | 2022-10-06 |
| 2 | 202111044084-FORM 4 [29-11-2023(online)].pdf | 2023-11-29 |
| 2 | 202111044084-POWER OF AUTHORITY [29-09-2021(online)].pdf | 2021-09-29 |
| 3 | 202111044084-ASSIGNMENT WITH VERIFIED COPY [06-10-2022(online)].pdf | 2022-10-06 |
| 3 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI [06-10-2022(online)].pdf | 2022-10-06 |
| 3 | 202111044084-FORM FOR STARTUP [29-09-2021(online)].pdf | 2021-09-29 |
| 4 | 202111044084-FORM FOR SMALL ENTITY(FORM-28) [29-09-2021(online)].pdf | 2021-09-29 |
| 4 | 202111044084-FORM FOR SMALL ENTITY [06-10-2022(online)].pdf | 2022-10-06 |
| 4 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI [06-10-2022(online)].pdf | 2022-10-06 |
| 5 | 202111044084-FORM-16 [06-10-2022(online)].pdf | 2022-10-06 |
| 5 | 202111044084-FORM FOR SMALL ENTITY [06-10-2022(online)].pdf | 2022-10-06 |
| 5 | 202111044084-FORM 1 [29-09-2021(online)].pdf | 2021-09-29 |
| 6 | 202111044084-POWER OF AUTHORITY [06-10-2022(online)].pdf | 2022-10-06 |
| 6 | 202111044084-FORM-16 [06-10-2022(online)].pdf | 2022-10-06 |
| 6 | 202111044084-FIGURE OF ABSTRACT [29-09-2021(online)].jpg | 2021-09-29 |
| 7 | 202111044084-POWER OF AUTHORITY [06-10-2022(online)].pdf | 2022-10-06 |
| 7 | 202111044084-IntimationOfGrant09-09-2022.pdf | 2022-09-09 |
| 7 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [29-09-2021(online)].pdf | 2021-09-29 |
| 8 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI [29-09-2021(online)].pdf | 2021-09-29 |
| 8 | 202111044084-IntimationOfGrant09-09-2022.pdf | 2022-09-09 |
| 8 | 202111044084-PatentCertificate09-09-2022.pdf | 2022-09-09 |
| 9 | 202111044084-AMMENDED DOCUMENTS [13-07-2022(online)].pdf | 2022-07-13 |
| 9 | 202111044084-DRAWINGS [29-09-2021(online)].pdf | 2021-09-29 |
| 9 | 202111044084-PatentCertificate09-09-2022.pdf | 2022-09-09 |
| 10 | 202111044084-AMMENDED DOCUMENTS [13-07-2022(online)].pdf | 2022-07-13 |
| 10 | 202111044084-DECLARATION OF INVENTORSHIP (FORM 5) [29-09-2021(online)].pdf | 2021-09-29 |
| 10 | 202111044084-FORM 13 [13-07-2022(online)].pdf | 2022-07-13 |
| 11 | 202111044084-COMPLETE SPECIFICATION [29-09-2021(online)].pdf | 2021-09-29 |
| 11 | 202111044084-FORM 13 [13-07-2022(online)].pdf | 2022-07-13 |
| 11 | 202111044084-MARKED COPIES OF AMENDEMENTS [13-07-2022(online)].pdf | 2022-07-13 |
| 12 | 202111044084-MARKED COPIES OF AMENDEMENTS [13-07-2022(online)].pdf | 2022-07-13 |
| 12 | 202111044084-STARTUP [29-01-2022(online)].pdf | 2022-01-29 |
| 12 | 202111044084-Written submissions and relevant documents [13-07-2022(online)].pdf | 2022-07-13 |
| 13 | 202111044084-Written submissions and relevant documents [13-07-2022(online)].pdf | 2022-07-13 |
| 13 | 202111044084-RELEVANT DOCUMENTS [29-01-2022(online)].pdf | 2022-01-29 |
| 13 | 202111044084-Correspondence to notify the Controller [25-06-2022(online)].pdf | 2022-06-25 |
| 14 | 202111044084-Correspondence to notify the Controller [25-06-2022(online)].pdf | 2022-06-25 |
| 14 | 202111044084-POA [29-01-2022(online)].pdf | 2022-01-29 |
| 14 | 202111044084-US(14)-HearingNotice-(HearingDate-28-06-2022).pdf | 2022-05-25 |
| 15 | 202111044084-ABSTRACT [08-04-2022(online)].pdf | 2022-04-08 |
| 15 | 202111044084-FORM28 [29-01-2022(online)].pdf | 2022-01-29 |
| 15 | 202111044084-US(14)-HearingNotice-(HearingDate-28-06-2022).pdf | 2022-05-25 |
| 16 | 202111044084-ABSTRACT [08-04-2022(online)].pdf | 2022-04-08 |
| 16 | 202111044084-CLAIMS [08-04-2022(online)].pdf | 2022-04-08 |
| 16 | 202111044084-FORM-9 [29-01-2022(online)].pdf | 2022-01-29 |
| 17 | 202111044084-CLAIMS [08-04-2022(online)].pdf | 2022-04-08 |
| 17 | 202111044084-DRAWING [08-04-2022(online)].pdf | 2022-04-08 |
| 17 | 202111044084-FORM 18A [29-01-2022(online)].pdf | 2022-01-29 |
| 18 | 202111044084-DRAWING [08-04-2022(online)].pdf | 2022-04-08 |
| 18 | 202111044084-FER_SER_REPLY [08-04-2022(online)].pdf | 2022-04-08 |
| 18 | 202111044084-FORM 13 [29-01-2022(online)].pdf | 2022-01-29 |
| 19 | 202111044084-Abstract-[08-02-2022].pdf | 2022-02-08 |
| 19 | 202111044084-FER.pdf | 2022-03-21 |
| 19 | 202111044084-FER_SER_REPLY [08-04-2022(online)].pdf | 2022-04-08 |
| 20 | 202111044084-FER.pdf | 2022-03-21 |
| 20 | 202111044084-Proof of Right [22-02-2022(online)].pdf | 2022-02-22 |
| 21 | 202111044084-Proof of Right [22-02-2022(online)].pdf | 2022-02-22 |
| 21 | 202111044084-FER.pdf | 2022-03-21 |
| 21 | 202111044084-Abstract-[08-02-2022].pdf | 2022-02-08 |
| 22 | 202111044084-Abstract-[08-02-2022].pdf | 2022-02-08 |
| 22 | 202111044084-FER_SER_REPLY [08-04-2022(online)].pdf | 2022-04-08 |
| 22 | 202111044084-FORM 13 [29-01-2022(online)].pdf | 2022-01-29 |
| 23 | 202111044084-DRAWING [08-04-2022(online)].pdf | 2022-04-08 |
| 23 | 202111044084-FORM 13 [29-01-2022(online)].pdf | 2022-01-29 |
| 23 | 202111044084-FORM 18A [29-01-2022(online)].pdf | 2022-01-29 |
| 24 | 202111044084-FORM-9 [29-01-2022(online)].pdf | 2022-01-29 |
| 24 | 202111044084-FORM 18A [29-01-2022(online)].pdf | 2022-01-29 |
| 24 | 202111044084-CLAIMS [08-04-2022(online)].pdf | 2022-04-08 |
| 25 | 202111044084-FORM-9 [29-01-2022(online)].pdf | 2022-01-29 |
| 25 | 202111044084-FORM28 [29-01-2022(online)].pdf | 2022-01-29 |
| 25 | 202111044084-ABSTRACT [08-04-2022(online)].pdf | 2022-04-08 |
| 26 | 202111044084-FORM28 [29-01-2022(online)].pdf | 2022-01-29 |
| 26 | 202111044084-POA [29-01-2022(online)].pdf | 2022-01-29 |
| 26 | 202111044084-US(14)-HearingNotice-(HearingDate-28-06-2022).pdf | 2022-05-25 |
| 27 | 202111044084-Correspondence to notify the Controller [25-06-2022(online)].pdf | 2022-06-25 |
| 27 | 202111044084-POA [29-01-2022(online)].pdf | 2022-01-29 |
| 27 | 202111044084-RELEVANT DOCUMENTS [29-01-2022(online)].pdf | 2022-01-29 |
| 28 | 202111044084-Written submissions and relevant documents [13-07-2022(online)].pdf | 2022-07-13 |
| 28 | 202111044084-STARTUP [29-01-2022(online)].pdf | 2022-01-29 |
| 28 | 202111044084-RELEVANT DOCUMENTS [29-01-2022(online)].pdf | 2022-01-29 |
| 29 | 202111044084-COMPLETE SPECIFICATION [29-09-2021(online)].pdf | 2021-09-29 |
| 29 | 202111044084-MARKED COPIES OF AMENDEMENTS [13-07-2022(online)].pdf | 2022-07-13 |
| 29 | 202111044084-STARTUP [29-01-2022(online)].pdf | 2022-01-29 |
| 30 | 202111044084-COMPLETE SPECIFICATION [29-09-2021(online)].pdf | 2021-09-29 |
| 30 | 202111044084-DECLARATION OF INVENTORSHIP (FORM 5) [29-09-2021(online)].pdf | 2021-09-29 |
| 30 | 202111044084-FORM 13 [13-07-2022(online)].pdf | 2022-07-13 |
| 31 | 202111044084-AMMENDED DOCUMENTS [13-07-2022(online)].pdf | 2022-07-13 |
| 31 | 202111044084-DECLARATION OF INVENTORSHIP (FORM 5) [29-09-2021(online)].pdf | 2021-09-29 |
| 31 | 202111044084-DRAWINGS [29-09-2021(online)].pdf | 2021-09-29 |
| 32 | 202111044084-DRAWINGS [29-09-2021(online)].pdf | 2021-09-29 |
| 32 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI [29-09-2021(online)].pdf | 2021-09-29 |
| 32 | 202111044084-PatentCertificate09-09-2022.pdf | 2022-09-09 |
| 33 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI [29-09-2021(online)].pdf | 2021-09-29 |
| 33 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [29-09-2021(online)].pdf | 2021-09-29 |
| 33 | 202111044084-IntimationOfGrant09-09-2022.pdf | 2022-09-09 |
| 34 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [29-09-2021(online)].pdf | 2021-09-29 |
| 34 | 202111044084-FIGURE OF ABSTRACT [29-09-2021(online)].jpg | 2021-09-29 |
| 34 | 202111044084-POWER OF AUTHORITY [06-10-2022(online)].pdf | 2022-10-06 |
| 35 | 202111044084-FIGURE OF ABSTRACT [29-09-2021(online)].jpg | 2021-09-29 |
| 35 | 202111044084-FORM 1 [29-09-2021(online)].pdf | 2021-09-29 |
| 35 | 202111044084-FORM-16 [06-10-2022(online)].pdf | 2022-10-06 |
| 36 | 202111044084-FORM 1 [29-09-2021(online)].pdf | 2021-09-29 |
| 36 | 202111044084-FORM FOR SMALL ENTITY [06-10-2022(online)].pdf | 2022-10-06 |
| 36 | 202111044084-FORM FOR SMALL ENTITY(FORM-28) [29-09-2021(online)].pdf | 2021-09-29 |
| 37 | 202111044084-FORM FOR STARTUP [29-09-2021(online)].pdf | 2021-09-29 |
| 37 | 202111044084-FORM FOR SMALL ENTITY(FORM-28) [29-09-2021(online)].pdf | 2021-09-29 |
| 37 | 202111044084-EVIDENCE FOR REGISTRATION UNDER SSI [06-10-2022(online)].pdf | 2022-10-06 |
| 38 | 202111044084-POWER OF AUTHORITY [29-09-2021(online)].pdf | 2021-09-29 |
| 38 | 202111044084-FORM FOR STARTUP [29-09-2021(online)].pdf | 2021-09-29 |
| 38 | 202111044084-ASSIGNMENT WITH VERIFIED COPY [06-10-2022(online)].pdf | 2022-10-06 |
| 39 | 202111044084-STATEMENT OF UNDERTAKING (FORM 3) [29-09-2021(online)].pdf | 2021-09-29 |
| 39 | 202111044084-POWER OF AUTHORITY [29-09-2021(online)].pdf | 2021-09-29 |
| 39 | 202111044084-FORM 4 [29-11-2023(online)].pdf | 2023-11-29 |
| 40 | 202111044084-STATEMENT OF UNDERTAKING (FORM 3) [29-09-2021(online)].pdf | 2021-09-29 |
| 40 | 202111044084-FORM 4 [21-12-2024(online)].pdf | 2024-12-21 |
| 1 | 202111044084E_16-03-2022.pdf |
| 1 | 202111044084patseersearchstE_03-03-2022.pdf |
| 2 | 202111044084E_16-03-2022.pdf |
| 2 | 202111044084patseersearchstE_03-03-2022.pdf |